Extracellular agonist that initiates the pathway.
Canonical JAK-STAT cytokine signaling pathway module
A taxon-neutral decomposition of the canonical JAK-STAT signal transduction pathway, the principal route by which type I/II cytokines and many hormones convert an extracellular signal into a direct change in gene transcription. The module is phrased as an ordered set of functions rather than a fixed gene list so it can represent the many receptor/JAK/STAT combinations that share the same mechanistic core: (1) a cytokine ligand binds and reorganizes a single-pass transmembrane receptor so that its intracellular domains are brought together; (2) receptor-associated Janus kinases (JAK1, JAK2, JAK3, TYK2) are juxtaposed and trans-activate by reciprocal tyrosine phosphorylation; (3) activated JAKs phosphorylate tyrosines on the receptor tails, creating phosphotyrosine docking sites; (4) latent cytoplasmic STAT transcription factors (STAT1-4, STAT5A, STAT5B, STAT6) are recruited via their SH2 domains and phosphorylated by the JAKs; (5) phosphorylated STATs dimerize through reciprocal SH2-phosphotyrosine contacts and translocate to the nucleus; (6) STAT dimers bind GAS/ISRE elements and drive transcription of cytokine-response genes; and (7) the response is terminated and tuned by SOCS/CIS proteins, protein tyrosine phosphatases (SHP1/SHP2, PTPN2), and PIAS SUMO ligases. Which JAKs and STATs are used is set by the receptor, captured here as variant sets along a receptor-class axis. The pathway is grounded in GO:0007259 (cell surface receptor signaling pathway via JAK-STAT).
This module is intentionally mechanism-centric and taxon/receptor-neutral. The ordered parts capture the invariant logic shared by every JAK-STAT receptor; the receptor-specific identity of the JAKs and STATs is represented as variant sets along a "receptor class" axis rather than baked into the trunk. Concrete realizations (e.g. the IFN-alpha/beta, IFN-gamma, IL-6/gp130, or common gamma-chain modules) specialize these variant sets and add the specific ligand, receptor chains, cell types, and target genes. Non-canonical and cross-talk features (unphosphorylated-STAT signaling, mitochondrial STAT3, serine phosphorylation, receptor-tyrosine-kinase- or GPCR-driven STAT activation) are out of scope for the canonical trunk and are noted where relevant. GO term ids in descriptors were checked against curated gene reviews in this repository; where no precise GO molecular function exists, only a preferred_term and description are given.
Derived QC
Recommended-field compliance
All recommended fields populated.
Module deep research
✗ none found
No MODULE:jak_stat_signaling deep-research report alongside the module YAML.
Leaf nodes lacking representative members
9 leaf node(s) with no concrete protein grounding:
- Cytokine binding and receptor reorganization ANY_WITH_FUNCTION
- Receptor tail phosphorylation and STAT docking-site creation FAMILY
- STAT dimerization and nuclear import FAMILY
- STAT-dependent transcription FAMILY
- Protein tyrosine phosphatase dephosphorylation ANY_WITH_FUNCTION
- PIAS SUMO-ligase restraint of nuclear STATs FAMILY
- Ras-MAPK branch interface ANY_WITH_FUNCTION
- PI3K-AKT-mTOR branch interface FAMILY
- RTK / Src / GPCR inputs into STATs ANY_WITH_FUNCTION
Template conformance
✓ every declared conforms_to bundle matches its template motif.
Gene-review completeness (8/10 grounded genes reviewed)
3 complete review(s) · 4 with deep research · 2 missing review · 4 reviewed but lacking deep research
| Gene | Review | Complete | Deep research |
|---|---|---|---|
| JAK1 P23458 | ✓ | ✓ | ✓ |
| JAK2 O60674 | ✗ | — | — |
| TYK2 P29597 | ✗ | — | — |
| SOCS1 O15524 | ✓ | 38/39 | ✗ |
| SOCS3 O14543 | ✓ | ✓ | ✗ |
| STAT1 P42224 | ✓ | 293/294 | ✓ |
| STAT2 P52630 | ✓ | ✓ | ✗ |
| STAT3 P40763 | ✓ | 454/456 | ✓ |
| STAT4 Q14765 | ✓ | 66/67 | ✓ |
| STAT5B P51692 | ✓ | 97/98 | ✗ |
Details
Connections
A cytokine (or hormone) ligand binds the extracellular domains of one or more single-pass transmembrane receptor chains, driving dimerization or a conformational change that repositions the receptor intracellular tails and their associated JAKs. The receptors themselves have no intrinsic catalytic activity; they act as scaffolds that present JAKs.
Annotons
Function
Locations
Ligand-binding scaffold that juxtaposes its associated JAKs upon cytokine engagement; provides the tyrosines that become STAT docks.
Ligand-induced receptor reorganization brings two receptor-bound Janus kinases into proximity. The kinases relieve pseudokinase-domain autoinhibition and trans-phosphorylate each other on activation-loop tyrosines, switching on their catalytic kinase domains. Which JAKs are used is dictated by the receptor (see variant set). JAKs are non-receptor (non-membrane-spanning) protein tyrosine kinases anchored to the receptor by their N-terminal FERM and SH2-like domains.
Annotons
Function
Locations
Receptor-proximal catalytic engine of the pathway; activated by trans-phosphorylation and in turn phosphorylates the receptor and STATs.
Each cytokine receptor recruits a characteristic pair (or, for some homodimeric hormone receptors, a single species) of JAKs. This variant set enumerates the canonical pairings; a concrete module selects the one matching its receptor.
IFN-alpha/beta via IFNAR1 (TYK2) and IFNAR2 (JAK1).
Annotons
IFN-gamma via IFNGR1 (JAK1) and IFNGR2 (JAK2).
Annotons
IL-6, IL-11, LIF, OSM, etc. via the shared gp130/IL6ST signal transducer, predominantly using JAK1 with JAK2 and TYK2.
Annotons
IL-2, IL-4, IL-7, IL-9, IL-15, IL-21 via the common gamma chain (IL2RG, bound by JAK3) paired with a cytokine-specific chain (bound by JAK1).
Annotons
Single-chain homodimeric receptors EPOR, MPL/TPOR, GHR, PRLR, G-CSFR, and leptin receptor signal predominantly through JAK2.
Annotons
JAK2 is the obligate kinase for erythropoietin, thrombopoietin, growth hormone, prolactin and GM-CSF/IL-3/IL-5 betac receptors; the JAK2 V617F mutation drives myeloproliferative neoplasms.
Activated JAKs phosphorylate specific tyrosine residues on the receptor cytoplasmic tails. The resulting phosphotyrosine motifs are recognized by the SH2 domains of latent STATs, recruiting them to the receptor and determining which STATs are engaged.
Annotons
Function
Generates phosphotyrosine docking motifs that confer STAT specificity on the receptor.
Latent cytoplasmic STATs are recruited to receptor phosphotyrosines via their SH2 domains and are then phosphorylated by the JAKs on a single conserved C-terminal tyrosine. Which STAT is engaged depends on the receptor docking site (variant set).
Annotons
Function
Processes
Latent signal-carrying substrate: docks onto the activated receptor and is converted by JAK phosphorylation into an active, dimerization-competent form.
Receptors select characteristic STATs. Common pairings: type I IFN -> STAT1+STAT2 (with IRF9); IFN-gamma -> STAT1; IL-6/gp130 -> STAT3; IL-12/IL-23 -> STAT4; gammac (IL-2/7/15), EPO, GH, prolactin -> STAT5A/STAT5B; IL-4/IL-13 -> STAT6.
Annotons
Annotons
Annotons
Annotons
Annotons
Phosphorylated STATs release from the receptor and form parallel dimers through reciprocal SH2-domain/phosphotyrosine interactions. Dimerization exposes/forms a nuclear localization signal recognized by importin-alpha (e.g. KPNA1), and the dimer is actively imported into the nucleus. Type I IFN forms the ISGF3 trimer (STAT1-STAT2-IRF9).
Annotons
Function
Locations
Converts the receptor-released phospho-STAT into a nuclear, DNA-binding-competent dimer.
Nuclear STAT dimers bind specific DNA elements - GAS (gamma-activated sequence, TTCnnnGAA) for STAT homodimers, or ISRE (interferon-stimulated response element) for the STAT1-STAT2-IRF9 ISGF3 complex - and recruit coactivators (CBP/p300) to activate transcription of cytokine-response genes. This is the terminal output that defines a JAK-STAT response.
Annotons
Function
Processes
Locations
Sequence-specific transcriptional activator that converts the cytokine signal into a defined gene-expression program (e.g. interferon-stimulated genes, acute-phase genes, lineage-commitment genes).
The response is self-limiting and tuned by multiple negative regulators acting at different steps: cytokine-inducible SOCS/CIS proteins (feedback inhibition of JAKs/receptors and SOCS-box-dependent degradation), protein tyrosine phosphatases that dephosphorylate JAKs, receptors and STATs (SHP1/PTPN6, SHP2/PTPN11, PTPN2/TC-PTP), and PIAS SUMO E3 ligases that restrain nuclear STAT activity.
STAT-induced SOCS/CIS proteins bind phospho-receptors/JAKs via their SH2 domains, inhibit JAK catalysis (SOCS1/SOCS3 via the kinase-inhibitory region) or compete for receptor docking sites (CIS), and target bound components for proteasomal degradation via the SOCS box/elongin-cullin ubiquitin ligase.
Annotons
Function
Processes
Cytokine-inducible negative-feedback brake that terminates and limits the duration of JAK-STAT signaling.
Protein tyrosine phosphatases reverse the activating phosphorylations: SHP1 (PTPN6) and SHP2 (PTPN11) act at the receptor/JAK level, and PTPN2 (TC-PTP) dephosphorylates JAKs and nuclear STATs, resetting the pathway.
Annotons
Function
Processes
Removes activating phosphotyrosines to terminate signaling.
PIAS (protein inhibitor of activated STAT) SUMO E3 ligases bind activated nuclear STAT dimers and restrain their transcriptional activity by blocking DNA binding, recruiting corepressors, or promoting SUMOylation.
Annotons
Processes
Restrains nuclear STAT activity, adding a nuclear layer of negative control.
The same ligand-activated receptor/JAK complex that drives STAT activation also branches into parallel "sidecar" pathways, and the STATs receive convergent inputs from them. These interfaces are not part of the canonical STAT trunk; each forks off the activated receptor and is curated as its own reusable module. Modeled here as interface nodes plus connections so the cross-talk is explicit without inlining the sidecar mechanisms.
Sidecar modules: MODULE:erk_cascade and MODULE:pi3k_akt_mtor. Both are reusable and are deployed by many other receptor systems (RTKs, GPCRs, integrins), which is why they are separate module documents rather than parts of this pathway. Additional non-canonical interfaces noted but not separately moduled: receptor-tyrosine-kinase- / Src- / GPCR-driven STAT activation that bypasses cytokine receptors, and non-canonical STAT outputs (unphosphorylated-STAT signaling, STAT3-NF-kB cross-talk, mitochondrial STAT3).
JAK-phosphorylated receptor tyrosines recruit GRB2/SHC adaptors and fork into the Ras-RAF-MEK-ERK cascade in parallel with STAT activation. ERK additionally converges back onto the STATs by phosphorylating their C-terminal serine (e.g. STAT1/STAT3 Ser727) to modulate maximal transcriptional activity. See MODULE:erk_cascade.
Annotons
Function
Convergent input that tunes STAT transcriptional output.
JAK-phosphorylated receptor tyrosines (frequently via IRS-1/IRS-2 adaptors, e.g. for IL-4 and growth-hormone receptors) recruit class I PI3K and fork into the PI3K-AKT-mTOR survival/growth axis in parallel with STAT activation. See MODULE:pi3k_akt_mtor.
Annotons
Function
Couples the activated cytokine receptor to the PI3K-AKT sidecar.
STATs (especially STAT3 and STAT5) can be tyrosine-phosphorylated independently of cytokine-receptor JAKs by receptor tyrosine kinases (EGFR, PDGFR), non-receptor kinases (c-Src, BCR-ABL), and downstream of GPCRs - a major route of STAT activation in cancer. Represented as an alternative input interface, not part of the canonical cytokine-receptor trunk.
Annotons
Processes
JAK-independent activation of STATs, converging on the same STAT trunk.